In focus · trending topic

chewing gum

5 stories · following the connections

AXIM Biotech Advisory Board Member Presented at CannMed 2017 Personalized Cannabinoid Medicine Conference at Harvard

By Nasdaq OMXApr 13, 2017, 1:01 PM UTC

AXIM Biotech Advisory Board Member Presented at CannMed 2017 Personalized Cannabinoid Medicine Conference at Harvard

By Nasdaq OMXApr 13, 2017, 1:01 PM UTC

AXIM Biotech Enters Term Sheet Agreement With US API Company to Develop Bioequivalent Product to Marinol

By Nasdaq OMXMar 28, 2017, 1:01 PM UTC

New U.S. Patent Allowance Granted to AXIM® Biotech for Use of All Cannabinoids in Its Controlled-Release Chewing Gum Products

By Nasdaq OMXNov 16, 2016, 2:01 PM UTC

New U.S. Patent Allowance Granted to AXIM® Biotech for Use of All Cannabinoids in Its Controlled-Release Chewing Gum Products

By Nasdaq OMXNov 16, 2016, 2:01 PM UTC